Mesalazine Prolonged Release Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP offers premium-quality Mesalazine Prolonged Release Tablets developed for advanced gastrointestinal and inflammatory bowel disease management. This prolonged-release formulation is widely prescribed for ulcerative colitis, inflammatory bowel disease (IBD), intestinal inflammation, and long-term gastrointestinal care therapies. Mesalazine works locally in the intestinal tract to reduce inflammation, control symptoms, and help maintain remission in chronic inflammatory bowel conditions. The prolonged-release technology ensures controlled drug delivery for sustained therapeutic action and improved patient management in chronic gastrointestinal disorders.

As a trusted Mesalazine Prolonged Release Tablets Manufacturer in India, Mesalazine Exporter in India, and Contract Pharmaceutical Manufacturer in Gujarat, Genliva Wellness LLP supplies high-quality gastroenterology formulations to domestic and international pharmaceutical markets. Manufactured under stringent GMP-compliant quality systems, the product ensures formulation stability, therapeutic consistency, and reliable pharmaceutical performance. With expertise in third party pharmaceutical manufacturing, private label gastrointestinal medicine manufacturing, and global pharmaceutical exports, the company supports healthcare distributors and pharmaceutical brands with dependable gastro care formulations for worldwide healthcare requirements.

Mesalazine Prolonged Release Tablets are specially formulated to provide controlled and sustained anti-inflammatory support for gastrointestinal care.

Prolonged-release formulation for sustained therapeutic action
Helps reduce intestinal inflammation effectively
Supports long-term inflammatory bowel disease management
Manufactured using high-quality pharmaceutical ingredients

This formulation is commonly prescribed in gastroenterology care for chronic inflammatory bowel and intestinal conditions.

Treatment of ulcerative colitis
Management of inflammatory bowel disease (IBD)
Helps reduce colon and intestinal inflammation
Supports maintenance therapy in gastrointestinal disorders
Effective for chronic inflammatory intestinal conditions
Used in long-term gastro care therapies

Mesalazine Prolonged Release Tablets provide sustained gastrointestinal anti-inflammatory support for improved long-term disease management.

Helps maintain prolonged therapeutic effectiveness
Supports controlled drug release and patient compliance
Reduces intestinal inflammation and discomfort effectively
Suitable for chronic gastrointestinal treatment protocols
Reliable pharmaceutical quality and formulation stability